ProfileGDS5678 / 1429167_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 15% 14% 15% 16% 15% 13% 15% 14% 15% 15% 14% 15% 15% 15% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3979815
GSM967853U87-EV human glioblastoma xenograft - Control 22.3580314
GSM967854U87-EV human glioblastoma xenograft - Control 32.3625115
GSM967855U87-EV human glioblastoma xenograft - Control 42.3401116
GSM967856U87-EV human glioblastoma xenograft - Control 52.3350215
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.390913
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3944415
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3337414
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3370615
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.3641515
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3334614
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3505815
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3572115
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3578215